GLABF (Gemina Laboratories) OCF Margin %: 0.00% (As of Oct. 2025)


What is Gemina Laboratories OCF Margin %?

Gemina Laboratories GLABF -27.59% OCF Margin % is 0.00% as of Oct. 2025. The stock has 2 warning signs investors should review.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Gemina Laboratories's Cash Flow from Operations for the three months ended in Oct. 2025 was $0.03 Mil. Gemina Laboratories's Revenue for the three months ended in Oct. 2025 was $0.00 Mil. Therefore, Gemina Laboratories's OCF Margin % for the quarter that ended in Oct. 2025 was 0.00%.

As of today, Gemina Laboratories's current OCF Yield % is 0.04%.

The historical rank and industry rank for Gemina Laboratories's OCF Margin % or its related term are showing as below:

GLABF' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 12.5

GLABF's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs GLABF: 12.50

Gemina Laboratories OCF Margin % Related Terms

Gemina Laboratories OCF Margin % Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories OCF Margin % Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
OCF Margin %
0.00 0.00 0.00 0.00 0.00

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 275.00 0.00 0.00

GLABF vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Gemina Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's OCF Margin % falls into.


Gemina Laboratories OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Gemina Laboratories's OCF Margin for the fiscal year that ended in Jan. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jan. 2025 )/Revenue (A: Jan. 2025 )
=-0.904/0
= %

Gemina Laboratories's OCF Margin for the quarter that ended in Oct. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Oct. 2025 )/Revenue (Q: Oct. 2025 )
=0.025/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Gemina Laboratories (GLABF) has a OCF Margin % of 0.00% as of Oct. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' OCF Margin % too high?
Gemina Laboratories' current OCF Margin % is 0.00%.
How does Gemina Laboratories' OCF Margin % compare to VRTX and REGN?
Gemina Laboratories' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current OCF Margin % is 0.00% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.